Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution
Matsukubo Jenna, Friesen Erik Loewen, MacDonald-Spracklin Rachael, Iseman Rachael, Solmi Marco, Fiedorowicz Jess G., Fischer Benedikt, Myran Daniel T.
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (22)
- Psilocybin Dispensaries and Online Health Claims in Canada. 2025-04-01 · Expand citations
- Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis? 2025-02-01 · Expand citations
- Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. 2023-04-14 · Expand citations
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. 2022-10-01 · Expand citations
- Back to the Future - The Therapeutic Potential of Psychedelic Drugs 2021-04-14 · Expand citations
- Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis. 2020-10-01 · Expand citations
- 10.1001/jamapsychiatry.2023.0549
- 10.1001/jamapsychiatry.2024.3532
- 10.1002/jcph.1995
- 10.1016/j.addbeh.2018.12.001
- 10.1016/j.drugalcdep.2019.107633
- 10.1016/j.drugalcdep.2025.112964
- 10.1016/j.euroneuro.2022.09.004
- 10.1016/j.jemermed.2022.12.025
- 10.1016/j.pharmthera.2003.11.002
- 10.1111/dar.13650
- 10.1177/0269881112439253
- 10.1371/journal.pmed.1004805
- 10.1503/cmaj.241191
- 10.26828/cannabis.2018.02.003
- 10.3390/ijerph13111050
- 10.4088/jcp.22l14505